Epithelial ovarian cancer,abbreviated as ovarian cancer,is the deadliest gynecologic malignancy,and platinum-based chemo-therapy remains the standard treatment option for ovarian cancer.Although most patients respond to platinum-based drug therapy,platinum resistance in recurrent ovarian cancer is inevitable.With poor prognosis,few treatment options,and limited efficacy in platinum-resistant recurrent ovarian cancer,the development of new therapeutic strategies is imminent.This article summarizes and discusses the current sta-tus of clinical treatment for platinum-resistant recurrent ovarian cancer and clinical advances in novel therapies.
维普
万方数据